| 181 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Medical Oncology |
2021 |
| 182 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Medical Oncology |
2021 |
| 183 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Anesthesia, Intensive care and Pain management |
2021 |
| 184 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Anesthesia, Intensive care and Pain management |
2021 |
| 185 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 186 |
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 187 |
Detection of del (16q) using the CBFB-MYH11 translocation dual fusion probe |
Department of Clinical Pathology |
2021 |
| 188 |
Effect of different doses of topical ketamine on hemodynamics in patients undergoing modified radical mastectomy |
Department of Anesthesia, Intensive care and Pain management |
2021 |
| 189 |
Ewing sarcoma outcomes in a country with limited resources: Egypt as an example |
Department of Medical Oncology |
2021 |
| 190 |
Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction |
Department of Clinical Pathology |
2021 |
